References
- Juran JM. Juran on quality by design: the new steps for planning quality into goods and services. New York: Simon and Schuster; 1992.
- Juran JM. A universal approach to managing for quality. Qual Progr. 1986;19(8):19–24.
- AAPS Workshop. Pharmaceutical quality assessment – a science and risk-based CMC approach in the 21st century; 2005 Oct 5–7; North Bethesda, MD.
- Lawrence XY. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008;25:781–791.
- US Food and Drug Administration. Quality by design for ANDAs: an example for immediate-release dosage forms. FDA, Rockville, MD: US Department of Health and Human Service; 2012.
- Guideline IH.Q8 (R2) Pharmaceutical Development. Step 4 Version. 2009.
- Food and Drug Administration. Guidance for industry: Q9 Quality risk management. Rockville, MD: DHHS; 2006.
- Moy A. EMEA and FDA approaches on the ICH Q10 on pharmaceutical quality system. Pharma Times 2009;41(8):15–18.
- Chudiwal V, Shahi S. Patent perspective of advanced gastroretentive drug delivery systems. Res J Pharm Dosag Form Technol. 2016;8:15–23.
- Hwang RC, Kowalski DL. Design of experiments for formulation development. California: Advanstar Communications Inc; 2005.
- ChemIDplus Chemical Information Classification [Accessed 27th November 2017]. Available from: https://chem.sis.nlm.nih.gov/chemidplus/chemidheavy.jsp.
- Sweetman SC. Martindale: the complete drug reference. 36th ed. London: Pharmaceutical Press; 2009.
- Chabria NB, Narayanan N. Formulation and in vitro evaluation of oral floating nicardipine hydrochloride tablets using polyethylene glycol 6000 and various HPMC grades. Pharmacophore 2014;5:494–508.
- Chabria NB, Narayanan N. Formulation and in vitro in vivo evaluation of oral floating nicardipine hydrochloride tablets using beeswax and various HPMC grades. Int J Med Pharma Sci. 2013;3:87–96.
- Chabria NB, Narayanan N. Formulation and in-vitro evaluation of oral floating nicardipine hydrochloride tablets. Hygeia-J Drugs Med. 2013;5:63–75.
- Moursy NM, Afifi NN, Ghorab DM, et al. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride. Die Pharmazie-Int J Pharm Sci. 2003;58:38–43.
- Takka S, Ocak ÖH, Acartürk F. Formulation and investigation of nicardipine HCl–alginate gel beads with factorial design-based studies. Eur J Pharm Sci. 1998;6:241–246.
- Lawrence XY, Amidon G, Khan MA, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16: 771–783.
- Pawar VK, Kansal S, Garg G, et al. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug Deliv. 2011;18:97–110.
- Chudiwal SS, Dehghan MH. Quality by design approach for development of suspension nasal spray products: a case study on budesonide nasal suspension. Drug Dev Ind Pharm. 2016;42:1643–1652.
- Gad SC, editor. Pharmaceutical manufacturing handbook: production and processes. New Jersey: John Wiley & Sons; 2008.
- Yerlikaya F, Ozgen A, Vural I, et al. Development and evaluation of paclitaxel nanoparticles using a quality‐by‐design approach. J Pharma Sci. 2013;102:3748–3761. Oct 1
- Inactive Ingredient Search for Approved Drug Products. [Accessed 27th November 2017]. Available from: https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
- Chudiwal VS, Shahi S, Chudiwal S. Development of sustained release gastro-retentive tablet formulation of bepotastine besilate using quality by design (QbD) approach. Indian Drugs 2017;54:48–60.
- Wilkinson L. Revising the Pareto chart. American Stat. 2006;60:332–334.
- Peterson JJ. A Bayesian approach to the ICH Q8 definition of design space. J Biopharm Stat. 2008 ;18:959–975.
- Pharmacopeia US. United States Pharmacopeia. The Standard. USA: US Pharmacopeia-39- National Formulary-34; 2016.
- Dissolution Methods – FDA [Accessed 27th November 2017]. Available from: https://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_getallData.cfm
- Badhan AC, Mashru RC, Shah PP, et al. Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection. AAPS Pharm Sci Tech. 2009;10:459–467.
- Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharma. 1983;15:25–35.